Menarini Silicon Biosystems, INC
2 clinical trials · Sponsor
◉ Watch Menarini Silicon Biosystems, INC
| Record | Firm | Date |
|---|---|---|
| A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients (NCT06833853) | Menarini Silicon Biosystems, INC | 2026-03-13 |
| ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC) (NCT05662345) | Menarini Silicon Biosystems, INC | 2022-12-12 |
Track Menarini Silicon Biosystems, INC automatically
Every clearance here is in the API, with alerts when new ones post.